
FDA Approves Pfizer’s RSV Vaccine for Older Adults, Expanding Protection Against Respiratory Illness
June 2, 2023
Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults has been approved by the US Food and Drug Administration (FDA), becoming the second vaccine against this common respiratory disease to receive approval. The FDA’s decision closely follows the approval of








